Sanders Capital, LLC Abb Vie Inc. Transaction History

Sanders Capital, LLC

  • $68.8 Billion
  • Q3 2024

A detailed history of Sanders Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sanders Capital, LLC holds 553,453 shares of ABBV stock, worth $92.8 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
553,453
Previous 554,848 0.25%
Holding current value
$92.8 Million
Previous $95.2 Million 14.85%
% of portfolio
0.16%
Previous 0.15%

Shares

43 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$163.84 - $199.33 $228,556 - $278,065
-1,395 Reduced 0.25%
553,453 $109 Million
Q2 2024

Aug 09, 2024
SELL
$154.79 - $180.76 $40,245 - $46,997
-260 Reduced 0.05%
554,848 $95.2 Million
Q1 2024

May 10, 2024
SELL
$159.82 - $182.1 $7,991 - $9,105
-50 Reduced 0.01%
555,108 $101 Million
Q4 2023

Feb 12, 2024
SELL
$137.6 - $154.97 $41,280 - $46,491
-300 Reduced 0.05%
555,158 $86 Million
Q3 2023

Nov 09, 2023
BUY
$133.59 - $154.65 $46,756 - $54,127
350 Added 0.06%
555,458 $82.8 Million
Q2 2023

Aug 11, 2023
SELL
$132.51 - $164.9 $3.87 Million - $4.81 Million
-29,190 Reduced 5.0%
555,108 $74.8 Million
Q1 2023

May 10, 2023
BUY
$144.61 - $166.54 $221,253 - $254,806
1,530 Added 0.26%
584,298 $93.1 Million
Q4 2022

Feb 10, 2023
SELL
$138.31 - $165.87 $623,778 - $748,073
-4,510 Reduced 0.77%
582,768 $94.2 Million
Q3 2022

Feb 17, 2023
BUY
$134.21 - $153.93 $605,287 - $694,224
4,510 Added 0.77%
587,278 $78.8 Million
Q3 2022

Nov 14, 2022
SELL
$134.21 - $153.93 $220,104 - $252,445
-1,640 Reduced 0.28%
587,278 $78.8 Million
Q2 2022

Aug 12, 2022
SELL
$137.62 - $174.96 $243,587 - $309,679
-1,770 Reduced 0.3%
588,918 $90.2 Million
Q1 2022

May 20, 2022
SELL
$131.98 - $163.75 $208,528 - $258,725
-1,580 Reduced 0.27%
590,688 $95.8 Million
Q4 2021

Feb 14, 2022
BUY
$107.43 - $135.93 $295,432 - $373,807
2,750 Added 0.47%
592,268 $80.2 Million
Q3 2021

Nov 12, 2021
SELL
$106.4 - $120.78 $266,000 - $301,950
-2,500 Reduced 0.42%
589,518 $63.6 Million
Q2 2021

Aug 06, 2021
BUY
$105.21 - $117.21 $6,312 - $7,032
60 Added 0.01%
592,018 $66.7 Million
Q1 2021

May 07, 2021
SELL
$102.3 - $112.62 $276,210 - $304,074
-2,700 Reduced 0.45%
591,958 $64.1 Million
Q4 2020

Feb 11, 2021
SELL
$80.49 - $108.67 $6.11 Million - $8.25 Million
-75,900 Reduced 11.32%
594,658 $63.7 Million
Q3 2020

Nov 12, 2020
SELL
$85.91 - $100.83 $2.57 Million - $3.02 Million
-29,965 Reduced 4.28%
670,558 $58.7 Million
Q2 2020

Aug 11, 2020
SELL
$73.37 - $98.18 $1.12 Million - $1.5 Million
-15,300 Reduced 2.14%
700,523 $68.8 Million
Q1 2020

May 28, 2020
SELL
$64.5 - $97.79 $1.45 Million - $2.2 Million
-22,500 Reduced 3.05%
715,823 $54.5 Million
Q4 2019

Jan 30, 2020
BUY
$72.13 - $90.25 $8.41 Million - $10.5 Million
116,590 Added 18.75%
738,323 $65.4 Million
Q2 2019

Jul 23, 2019
BUY
$65.7 - $83.98 $32,850 - $41,990
500 Added 0.08%
621,733 $45.2 Million
Q1 2019

May 01, 2019
SELL
$77.14 - $90.79 $15,428 - $18,158
-200 Reduced 0.03%
621,233 $50.1 Million
Q3 2018

Oct 29, 2018
SELL
$88.91 - $98.84 $168,929 - $187,796
-1,900 Reduced 0.3%
621,433 $58.8 Million
Q2 2018

Jul 24, 2018
SELL
$89.78 - $106.23 $161,604 - $191,214
-1,800 Reduced 0.29%
623,333 $57.8 Million
Q1 2018

May 14, 2018
SELL
$92.01 - $123.21 $92,010 - $123,210
-1,000 Reduced 0.16%
625,133 $59.2 Million
Q4 2017

Jan 31, 2018
SELL
$89.56 - $98.21 $125,384 - $137,494
-1,400 Reduced 0.22%
626,133 $60.6 Million
Q2 2017

May 14, 2018
BUY
N/A
4,400 Added 0.71%
627,533 $45.5 Million
Q1 2017

Sep 07, 2022
SELL
N/A
-4,400 Reduced 0.7%
623,133 $40.6 Million
Q1 2017

May 24, 2022
BUY
N/A
4,400 Added 0.71%
627,533 $0
Q1 2017

May 14, 2018
SELL
N/A
-200 Reduced 0.03%
623,133 $40.6 Million
Q4 2016

May 14, 2018
SELL
N/A
-4,100 Reduced 0.65%
623,333 $39 Million
Q3 2016

May 25, 2022
SELL
N/A
-600 Reduced 0.1%
627,433 $39.6 Million
Q2 2016

May 25, 2022
BUY
N/A
2,504 Added 0.4%
628,033 $38.9 Million
Q4 2015

Sep 07, 2022
SELL
N/A
-17,994 Reduced 2.8%
625,529 $37.1 Million
Q3 2015

Sep 07, 2022
SELL
N/A
-9,100 Reduced 1.39%
643,523 $35 Million
Q2 2015

Sep 07, 2022
SELL
N/A
-115,200 Reduced 15.0%
652,623 $43.9 Million
Q1 2015

Sep 07, 2022
SELL
N/A
-11,162 Reduced 1.43%
767,823 $44.9 Million
Q4 2014

Sep 07, 2022
BUY
N/A
2,200 Added 0.28%
778,985 $51 Million
Q1 2014

Sep 07, 2022
SELL
N/A
-5,354 Reduced 0.68%
776,785 $39.9 Million
Q4 2013

Sep 07, 2022
SELL
N/A
-1,700 Reduced 0.22%
782,139 $41.3 Million
Q2 2013

Sep 07, 2022
SELL
N/A
-400 Reduced 0.05%
783,839 $32.4 Million
Q1 2013

Sep 07, 2022
BUY
N/A
784,239
784,239 $32 Million

Others Institutions Holding ABBV

# of Institutions
3,846
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sanders Capital, LLC Portfolio

Follow Sanders Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanders Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanders Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email